• 2021
  Plaze M, Attali D, Prot M, Petit AC, Blatzer M, Vinckier F, Levillayer L, Chiaravalli J, Perin-Dureau F, Cachia A, Friedlander G, Chrétien F, Simon-Loriere E, Gaillard R, Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine., Int J Antimicrob Agents 2021 Mar; 57(3): 106274.
• 2020
  Carrillo P, Petit AC, Gaillard R, Vinckier F, [The next psychoactive drugs: From imipramine to ketamine]., Bull Acad Natl Med 2020 Dec; 204(9): 1034-1042.
• 2020
  Carrillo P, Petit AC, Gaillard R, Vinckier F, The next psychoactive drugs: From imipramine to ketamine., Bull Acad Natl Med 2020 Dec; 204(9): e169-e177.
• 2020
  Plaze M, Attali D, Petit AC, Blatzer M, Simon-Loriere E, Vinckier F, Cachia A, Chrétien F, Gaillard R, Repurposing chlorpromazine to treat COVID-19: The reCoVery study., Encephale 2020 Jun; 46(3): 169-172.
• 2020
  Plaze M, Attali D, Petit AC, Blatzer M, Simon-Loriere E, Vinckier F, Cachia A, Chrétien F, Gaillard R, [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study]., Encephale 2020 Jun; 46(3S): S35-S39.
• 2020
  Bottemanne H, Bonnard E, Claret A, Petit AC, Gaillard R, Fossati P, Ketamine and Monoamine Oxidase Inhibitor Combination: Utility, Safety, Efficacy?, J Clin Psychopharmacol 2020 ; 40(6): 636-638.
• 2019
  Verdonk F, Petit AC, Abdel-Ahad P, Vinckier F, Jouvion G, de Maricourt P, De Medeiros GF, Danckaert A, Van Steenwinckel J, Blatzer M, Maignan A, Langeron O, Sharshar T, Callebert J, Launay JM, Chrétien F, Gaillard R., Microglial production of quinolinic acid as a target and a biomarker of the antidepressant effect of ketamine., Brain Behav Immun. 2019 Jun 28.
• 2018
  Petit AC, El Asmar K, David DJ, Gardier AM, Becquemont L, Fève B, Verstuyft C, Corruble E, The association of β-arrestin2 polymorphisms with response to antidepressant treatment in depressed patients, Prog. Neuropsychopharmacol. Biol. Psychiatry 2018 Feb;81:74-79.
• 2017
  Deflesselle E, Verstuyft C, Petit AC, Hardy P, David DJ, Falissard B, Fève B, Rigal L, Becquemont L, Corruble E, Colle R, No impact of eight NTRK2 genetic polymorphisms on 6-month antidepressant efficacy in depressed patients, Pharmacogenomics 2017 Mar;18(4):349-357.
• 2016
  Petit AC, Eutrope J, Thierry A, Bednarek N, Aupetit L, Saad S, Vulliez L, Sibertin-Blanc D, Nezelof S, Rolland AC, Mother’s Emotional and Posttraumatic Reactions after a Preterm Birth: The Mother-Infant Interaction Is at Stake 12 Months after Birth, PLoS ONE 2016;11(3):e0151091.
• 2016
  Qesseveur G, Petit AC, Nguyen HT, Dahan L, Colle R, Rotenberg S, Seif I, Robert P, David D, Guilloux JP, Gardier AM, Verstuyft C, Becquemont L, Corruble E, Guiard BP, Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach, Neuropharmacology 2016 06;105:142-153.
• 2016
  Petit AC, Hozer F, Youssov K, Lavaud P, Hardy P, Mouaffak F, Differential Response to ECT of Psychotic and Affective Symptoms in Huntington’s Disease: A Case Report, J Neuropsychiatry Clin Neurosci 2016;28(1):e3-5.
• 2015
  Corruble E, El Asmar K, Trabado S, Verstuyft C, Falissard B, Colle R, Petit AC, Gressier F, Brailly-Tabard S, Ferreri F, Lépine JP, Haffen E, Polosan M, Bourrier C, Perlemuter G, Chanson P, Fève B, Becquemont L, Treating major depressive episodes with antidepressants can induce or worsen metabolic syndrome: results of the METADAP cohort, World Psychiatry 2015 Oct;14(3):366-7.
• 2015
  Colle R, Gressier F, Verstuyft C, Deflesselle E, Lépine JP, Ferreri F, Hardy P, Guilloux JP, Petit AC, Fève B, Falissard B, Becquemont L, Corruble E, Brain-derived neurotrophic factor Val66Met polymorphism and 6-month antidepressant remission in depressed Caucasian patients, J Affect Disord 2015 Apr;175:233-40.
• 2014
  Petit AC, Quesseveur G, Gressier F, Colle R, David DJ, Gardier AM, Ferreri F, Lépine JP, Falissard B, Verstuyft C, Guiard BP, Corruble E, Converging translational evidence for the involvement of the serotonin 2A receptor gene in major depressive disorder, Prog. Neuropsychopharmacol. Biol. Psychiatry 2014 Oct;54:76-82.
• 2014
  Chevalier C, Nicolas JF, Petit AC, Preparation and delivery of 4-hydroxy-tamoxifen for clonal and polyclonal labeling of cells of the surface ectoderm, skin, and hair follicle, Methods Mol. Biol. 2014;1195:239-45.
• 2009
  Petit AC, Nicolas JF, Large-scale clonal analysis reveals unexpected complexity in surface ectoderm morphogenesis, PLoS ONE 2009;4(2):e4353.
• 2005
  Petit AC, Legué E, Nicolas JF, Methods in clonal analysis and applications, Reprod. Nutr. Dev. 2005 May-Jun;45(3):321-39.
• 2005
  Maroto M, Dale JK, Dequéant ML, Petit AC, Pourquié O, Synchronised cycling gene oscillations in presomitic mesoderm cells require cell-cell contact, Int. J. Dev. Biol. 2005;49(2-3):309-15.